Developing an Oncology Workforce for the 21st Century

培养 21 世纪的肿瘤学劳动力

基本信息

批准号：
7894004
负责人：
OLUFUNMILAYO F. OLOPADE
金额：
$ 57.16万
依托单位：
UNIVERSITY OF CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-08-12 至 2015-07-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): The University of Chicago has long recognized the importance of physician scientists capable of utilizing laboratory discoveries to evolve novel therapeutic approaches and using clinical observations to inform and shape basic investigations. The University has an enviable record of training the next generation of academic oncologists. However, the training of academic leaders with critical expertise in clinical and translational research has become increasingly difficult, mandating the creation of a tightly structured and mentored training environment. Leveraging our current training programs (CTSA, K30 award, non-Roadmap K12 awards, traditional T32 training, K08/K23 mentoring programs), we will create an interdisciplinary program in patient-oriented research to train clinicians and basic scientists to lead interdisciplinary teams that will transform the practice of oncology. The Paul Calabresi K12 Scholars Program is our highly mentored, didactic coursework-intensive program, and "hands on" clinical research training which results in a Master of Science in Health Studies. These scholars are clinical oncologists finishing fellowship training, clinical faculty who wish to change career emphasis, or a scientist with a health-related PhD who wishes to work in the clinical sphere. The strength of our clinical programs coupled with our research intensity and our focus on genetics/genomics research makes the University of Chicago an ideal institution for the preparation of a clinical oncology workforce for the era of personalized medicine. Through this training program will emerge bonafide translational researchers and clinical oncologists who will possess the knowledge and capacity to conduct bench to bedside research and translate their findings back to patients and the population. It is our expectation that individuals completing this program will have obtained the broad research training and comprehensive experience necessary to perform high quality and high impact hypothesis-based clinical and translational research and to make fundamental contributions towards the goal of personalized cancer treatment. An explicit goal of this Paul Calabresi Scholars program, as with all training programs in our institution, is that its training opportunities and benefits will extend far beyond the relatively few scholars whose stipends it will provide. We are confident that the program will reach into the larger oncology trainee community at our University and in Chicago and to young scientists pursuing careers in cancer research all over the globe. Thus, the benefit that accrues from the program's implementation will be substantial.

描述（由申请人提供）：芝加哥大学长期以来一直认识到医学科学家的重要性，他们能够利用实验室发现来发展新的治疗方法，并利用临床观察来指导和塑造基础研究。该大学在培养下一代学术肿瘤学家方面拥有令人羡慕的记录。然而，培养具有临床和转化研究关键专业知识的学术领导者变得越来越困难，需要创建一个结构严密、受指导的培训环境。利用我们现有的培训计划（CTSA、K30 奖项、非路线图 K12 奖项、传统 T32 培训、K08/K23 指导计划），我们将创建一个以患者为中心的跨学科研究项目，培训临床医生和基础科学家领导跨学科团队，将改变肿瘤学的实践。 Paul Calabresi K12 学者计划是我们的高度指导、教学课程密集型计划，以及“实践”临床研究培训，可授予健康研究理学硕士学位。这些学者是完成进修培训的临床肿瘤学家、希望改变职业重点的临床教员，或者是拥有健康相关博士学位但希望在临床领域工作的科学家。我们的临床项目实力加上我们的研究强度和对遗传学/基因组学研究的关注，使芝加哥大学成为个性化医疗时代培养临床肿瘤学劳动力的理想机构。通过这个培训计划，将出现真正的转化研究人员和临床肿瘤学家，他们将拥有进行从实验室到临床研究的知识和能力，并将他们的研究结果转化为患者和大众。我们期望完成该计划的个人将获得进行高质量和高影响力的基于假设的临床和转化研究所需的广泛的研究培训和全面的经验，并为个性化癌症治疗的目标做出基本贡献。与我们机构的所有培训计划一样，保罗·卡拉布雷西学者计划的一个明确目标是，其培训机会和福利将远远超出其提供的津贴相对较少的学者。我们相信，该计划将惠及我们大学和芝加哥更大的肿瘤学实习生社区，以及全球范围内从事癌症研究事业的年轻科学家。因此，该计划的实施所带来的效益将是巨大的。